{"entity":{"type":"insider","cik":"0001459688","url":"/insider/0001459688","json_url":"/insider/0001459688.json","name":"21 APRIL FUND, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":11,"first":"2010-06-22","last":"2019-06-24","span_basis":"filed_date"},"name_variants":[{"name":"21 APRIL FUND, L.P.","source":"filing","n_filings":4,"first_seen":"2016-04-27","last_seen":"2019-06-24"},{"name":"21 APRIL FUND LP","source":"filing","n_filings":7,"first_seen":"2010-06-22","last_seen":"2016-01-12"}],"transactions":[{"id":7903755,"accession":"0001567619-19-013856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-013856","line_url":"/filing/0001567619-19-013856#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; 21 APRIL FUND, L.P.; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000000.0,"shares_display":"4,000,000","price_per_share":0.52,"price_display":"0.52","price_state":"stated","total_value":2080000.0,"total_display":"2,080,000.00","shares_owned_after":26476546.0,"shares_owned_after_display":"26,476,546","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-20","filed_date":"2019-06-24","scope":"insider"},{"id":2386630,"accession":"0001140361-16-084885","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-084885","line_url":"/filing/0001140361-16-084885#line-3","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, L.P.; 21 APRIL FUND, LTD.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.18,"price_display":"1.18","price_state":"stated","total_value":59000.0,"total_display":"59,000.00","shares_owned_after":22431546.0,"shares_owned_after_display":"22,431,546","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-03","filed_date":"2016-11-04","scope":"insider"},{"id":2386625,"accession":"0001140361-16-084885","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-084885","line_url":"/filing/0001140361-16-084885#line-2","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, L.P.; 21 APRIL FUND, LTD.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":1.1399,"price_display":"1.14","price_state":"stated","total_value":28497.5,"total_display":"28,497.50","shares_owned_after":22456546.0,"shares_owned_after_display":"22,456,546","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-03","filed_date":"2016-11-04","scope":"insider"},{"id":2386617,"accession":"0001140361-16-084885","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-084885","line_url":"/filing/0001140361-16-084885#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Investment Management, LLC; 21 APRIL FUND, L.P.; 21 APRIL FUND, LTD.; First Eagle Value in Biotechnology Master Fund, Ltd.; First Eagle Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":22800.0,"total_display":"22,800.00","shares_owned_after":22476546.0,"shares_owned_after_display":"22,476,546","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-03","filed_date":"2016-11-04","scope":"insider"},{"id":2171962,"accession":"0001140361-16-080886","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-080886","line_url":"/filing/0001140361-16-080886#line-3","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"21 APRIL FUND, L.P.; First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1981224.0,"shares_display":"1,981,224","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":2298219.84,"total_display":"2,298,219.84","shares_owned_after":21862770.0,"shares_owned_after_display":"21,862,770","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-26","filed_date":"2016-09-28","scope":"insider"},{"id":2171960,"accession":"0001140361-16-080886","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-080886","line_url":"/filing/0001140361-16-080886#line-2","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"21 APRIL FUND, L.P.; First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":318776.0,"shares_display":"318,776","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":350653.6,"total_display":"350,653.60","shares_owned_after":22181546.0,"shares_owned_after_display":"22,181,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-26","filed_date":"2016-09-28","scope":"insider"},{"id":2171956,"accession":"0001140361-16-080886","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-080886","line_url":"/filing/0001140361-16-080886#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"21 APRIL FUND, L.P.; First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.15,"price_display":"1.15","price_state":"stated","total_value":230000.0,"total_display":"230,000.00","shares_owned_after":22381546.0,"shares_owned_after_display":"22,381,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-26","filed_date":"2016-09-28","scope":"insider"},{"id":2887726,"accession":"0001140361-16-062146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-062146","line_url":"/filing/0001140361-16-062146#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Holdings, Inc.; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND, LTD.; 21 APRIL FUND, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500000.0,"shares_display":"5,500,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":6875000.0,"total_display":"6,875,000.00","shares_owned_after":19881546.0,"shares_owned_after_display":"19,881,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-26","filed_date":"2016-04-27","scope":"insider"},{"id":2742495,"accession":"0001140361-16-047642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-16-047642","line_url":"/filing/0001140361-16-047642#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"21 APRIL FUND LTD; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND LP; Arnhold & S. Bleichroeder Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300100.0,"shares_display":"300,100","price_per_share":1.368,"price_display":"1.37","price_state":"stated","total_value":410536.8,"total_display":"410,536.80","shares_owned_after":14381546.0,"shares_owned_after_display":"14,381,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-11","filed_date":"2016-01-12","scope":"insider"},{"id":8150131,"accession":"0001140361-15-036416","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-036416","line_url":"/filing/0001140361-15-036416#line-2","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"21 APRIL FUND LP; 21 APRIL FUND LTD; First Eagle Value in Biotechnology Master Fund, Ltd.; Arnhold & S. Bleichroeder Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":885049.0,"shares_display":"885,049","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":1593088.2,"total_display":"1,593,088.20","shares_owned_after":14081446.0,"shares_owned_after_display":"14,081,446","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-29","filed_date":"2015-10-01","scope":"insider"},{"id":8150123,"accession":"0001140361-15-036416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-036416","line_url":"/filing/0001140361-15-036416#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"21 APRIL FUND LP; 21 APRIL FUND LTD; First Eagle Value in Biotechnology Master Fund, Ltd.; Arnhold & S. Bleichroeder Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":67200.0,"shares_display":"67,200","price_per_share":1.59,"price_display":"1.59","price_state":"stated","total_value":106848.0,"total_display":"106,848.00","shares_owned_after":13196397.0,"shares_owned_after_display":"13,196,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-10-01","scope":"insider"},{"id":8804892,"accession":"0001459688-15-000002","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001459688-15-000002","line_url":"/filing/0001459688-15-000002#line-6","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND LTD; 21 APRIL FUND LP; Arnhold & S. Bleichroeder Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.66,"price_display":"1.66","price_state":"stated","total_value":166000.0,"total_display":"166,000.00","shares_owned_after":13129397.0,"shares_owned_after_display":"13,129,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-20","scope":"insider"},{"id":8804891,"accession":"0001459688-15-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001459688-15-000002","line_url":"/filing/0001459688-15-000002#line-5","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND LTD; 21 APRIL FUND LP; Arnhold & S. Bleichroeder Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":168800.0,"shares_display":"168,800","price_per_share":1.66,"price_display":"1.66","price_state":"stated","total_value":280208.0,"total_display":"280,208.00","shares_owned_after":13029197.0,"shares_owned_after_display":"13,029,197","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-13","filed_date":"2015-03-20","scope":"insider"},{"id":8804890,"accession":"0001459688-15-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001459688-15-000002","line_url":"/filing/0001459688-15-000002#line-4","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND LTD; 21 APRIL FUND LP; Arnhold & S. Bleichroeder Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.69,"price_display":"1.69","price_state":"stated","total_value":338000.0,"total_display":"338,000.00","shares_owned_after":12860397.0,"shares_owned_after_display":"12,860,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-12","filed_date":"2015-03-20","scope":"insider"},{"id":8804889,"accession":"0001459688-15-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001459688-15-000002","line_url":"/filing/0001459688-15-000002#line-3","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND LTD; 21 APRIL FUND LP; Arnhold & S. Bleichroeder Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":1.69,"price_display":"1.69","price_state":"stated","total_value":676000.0,"total_display":"676,000.00","shares_owned_after":12660397.0,"shares_owned_after_display":"12,660,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-11","filed_date":"2015-03-20","scope":"insider"},{"id":8804888,"accession":"0001459688-15-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001459688-15-000002","line_url":"/filing/0001459688-15-000002#line-2","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND LTD; 21 APRIL FUND LP; Arnhold & S. Bleichroeder Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":1.74,"price_display":"1.74","price_state":"stated","total_value":870000.0,"total_display":"870,000.00","shares_owned_after":12260397.0,"shares_owned_after_display":"12,260,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-10","filed_date":"2015-03-20","scope":"insider"},{"id":8804887,"accession":"0001459688-15-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001459688-15-000002","line_url":"/filing/0001459688-15-000002#line-1","is_derivative":false,"issuer_cik":"0001082038","issuer_name":"DURECT CORP","issuer_ticker":"DRRX","issuer_name_source":null,"issuer_url":"/issuer/0001082038","owner_cik":null,"owner_name":"First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND LTD; 21 APRIL FUND LP; Arnhold & S. Bleichroeder Holdings, Inc.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":1.69,"price_display":"1.69","price_state":"stated","total_value":507000.0,"total_display":"507,000.00","shares_owned_after":11760397.0,"shares_owned_after_display":"11,760,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-09","filed_date":"2015-03-20","scope":"insider"},{"id":4380481,"accession":"0000902664-13-003110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-13-003110","line_url":"/filing/0000902664-13-003110#line-1","is_derivative":false,"issuer_cik":"0000754094","issuer_name":"ARADIGM CORP","issuer_ticker":"ARDM","issuer_name_source":null,"issuer_url":"/issuer/0000754094","owner_cik":null,"owner_name":"DEF Associates Ltd.; 21 APRIL FUND LP; First Eagle Investment Management, LLC; DEF Associates LP; First Eagle Value in Biotechnology Master Fund, Ltd.; 21 APRIL FUND LTD","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, no par value (the \"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40322580.0,"shares_display":"40,322,580","price_per_share":0.124,"price_display":"0.12","price_state":"stated","total_value":4999999.92,"total_display":"4,999,999.92","shares_owned_after":null,"shares_owned_after_display":null,"ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-08-27","filed_date":"2013-08-29","scope":"insider"},{"id":3210319,"accession":"0000902664-12-001567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-12-001567","line_url":"/filing/0000902664-12-001567#line-1","is_derivative":false,"issuer_cik":"0000754094","issuer_name":"ARADIGM CORP","issuer_ticker":"ARDM","issuer_name_source":null,"issuer_url":"/issuer/0000754094","owner_cik":null,"owner_name":"21 APRIL FUND LP; 21 APRIL FUND LTD; First Eagle Investment Management, LLC; DEF Associates LP; DEF Associates Ltd.; First Eagle Value in Biotechnology Master Fund, Ltd.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, no par value (the \"Common Stock\")","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41666667.0,"shares_display":"41,666,667","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":5000000.04,"total_display":"5,000,000.04","shares_owned_after":114004319.0,"shares_owned_after_display":"114,004,319","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-11","filed_date":"2012-12-13","scope":"insider"},{"id":9189582,"accession":"0001457518-11-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457518-11-000001","line_url":"/filing/0001457518-11-000001#line-1","is_derivative":false,"issuer_cik":"0001013238","issuer_name":"ARADIGM CORP","issuer_ticker":"ARDM","issuer_name_source":null,"issuer_url":"/issuer/0001013238","owner_cik":null,"owner_name":"21 APRIL FUND LP; DEF Associates LP; 21 APRIL FUND LTD; First Eagle Value in Biotechnology Master Fund, Ltd.; DEF Associates N.V.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10625000.0,"shares_display":"10,625,000","price_per_share":0.19,"price_display":"0.19","price_state":"stated","total_value":2018750.0,"total_display":"2,018,750.00","shares_owned_after":71357909.0,"shares_owned_after_display":"71,357,909","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-07-07","filed_date":"2011-07-11","scope":"insider"},{"id":7535039,"accession":"0001457518-10-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001457518-10-000002","line_url":"/filing/0001457518-10-000002#line-1","is_derivative":false,"issuer_cik":"0001013238","issuer_name":"ARADIGM CORP","issuer_ticker":"ARDM","issuer_name_source":null,"issuer_url":"/issuer/0001013238","owner_cik":null,"owner_name":"21 APRIL FUND LP; First Eagle Value in Biotechnology Master Fund, Ltd.; DEF Associates N.V.; 21 APRIL FUND LTD","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19433408.0,"shares_display":"19,433,408","price_per_share":0.1184,"price_display":"0.12","price_state":"stated","total_value":2300915.5072,"total_display":"2,300,915.51","shares_owned_after":56517670.0,"shares_owned_after_display":"56,517,670","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-18","filed_date":"2010-06-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001082038","name":"DURECT CORP","url":"/issuer/0001082038","role":"Ten percent owner","n_filings":7,"first_seen":"2015-03-20","last_seen":"2019-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001013238","name":"ARADIGM CORP","url":"/issuer/0001013238","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2010-06-22","last_seen":"2013-08-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001459688","retrieved_at":"2026-08-21T17:53:43+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}